{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:39:16Z","timestamp":1773387556573,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CMRPG3B0441, CORPG3C0081."],"award-info":[{"award-number":["CMRPG3B0441, CORPG3C0081."]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41433-020-1066-y","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T12:03:49Z","timestamp":1594037029000},"page":"2098-2105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mycophenolate sodium in the treatment of corticosteroid-refractory non-infectious inflammatory uveitis (MySTRI study)"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1167-3406","authenticated-orcid":false,"given":"Tony S.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wing Man","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ijilmurun","family":"Enkh-Amgalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2744-3234","authenticated-orcid":false,"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"key":"1066_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjo.80.4.332","volume":"80","author":"A Rothova","year":"1996","unstructured":"Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:332\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1066_CR2","doi-asserted-by":"crossref","unstructured":"Jones NP. The Manchester Uveitis Clinic: the first 3000 patients, 2: Uveitis Manifestations, complications, medical and surgical management. Ocul Immunol Inflamm. 2015;23:127\u201334.","DOI":"10.3109\/09273948.2014.968671"},{"key":"1066_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1365-2990.2003.00499.x","volume":"29","author":"EH Hughes","year":"2003","unstructured":"Hughes EH, Dick AD. The pathology and pathogenesis of retinal vasculitis. Neuropathol Appl Neurobiol. 2003;29:325\u201340.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1066_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0165-5728(02)00208-4","volume":"130","author":"GM Verjans","year":"2002","unstructured":"Verjans GM, van Hagen PM, van der Kooi A, Osterhaus AD, Baarsma GS. Vgamma9Vdelta2 T cells recovered from eyes of patients with Behcet\u2019s disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol. 2002;130:46\u201354.","journal-title":"J Neuroimmunol"},{"key":"1066_CR5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/archopht.123.7.1000","volume":"123","author":"R Nussenblatt","year":"2005","unstructured":"Nussenblatt R. Treating intraocular inflammatory disease in the 21st century. Arch Ophthalmol. 2005;123:1000\u20131.","journal-title":"Arch Ophthalmol"},{"key":"1066_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.autrev.2004.08.004","volume":"4","author":"F Atzeni","year":"2005","unstructured":"Atzeni F, Sarzi-Puttini P, Doria A, Iaccarino L, Capsoni F. Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review. Autoimmun Rev. 2005;4:144\u201352.","journal-title":"Autoimmun Rev"},{"key":"1066_CR7","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(96)10310-X","volume":"348","author":"JJ Lipsky","year":"1996","unstructured":"Lipsky JJ. Mycophenolate mofetil. Lancet. 1996;348:1357\u20139.","journal-title":"Lancet"},{"key":"1066_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0161-6420(99)90078-7","volume":"106","author":"G Larkin","year":"1999","unstructured":"Larkin G, Lightman S. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease. Ophthalmology. 1999;106:370\u20134.","journal-title":"Ophthalmology"},{"key":"1066_CR9","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0161-6420(03)00092-7","volume":"110","author":"S Baltatzis","year":"2003","unstructured":"Baltatzis S, Tufail F, Yu EN, Vredeveld CM, Foster CS. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology. 2003;110:1061\u20135.","journal-title":"Ophthalmology"},{"key":"1066_CR10","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.ophtha.2005.02.020","volume":"112","author":"JE Thorne","year":"2005","unstructured":"Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology. 2005;112:1472\u20137.","journal-title":"Ophthalmology"},{"key":"1066_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ajo.2016.06.004","volume":"168","author":"E Shen","year":"2016","unstructured":"Shen E, Rathinam SR, Babu M, Kanakath A, Thundikandy R, Lee SM, et al. Outcomes of Vogt-Koyanagi-Harada disease: a subanalysis from a randomized clinical trial of antimetabolite therapies. Am J Ophthalmol. 2016;168:279\u201386.","journal-title":"Am J Ophthalmol"},{"key":"1066_CR12","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/j.1600-6143.2006.01693.x","volume":"7","author":"K Budde","year":"2007","unstructured":"Budde K, Bauer S, Hambach P, Hahn U, Roblitz H, Mai I, et al. Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients. Am J Transpl. 2007;7:888\u201398.","journal-title":"Am J Transpl"},{"key":"1066_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","volume":"66","author":"J Kobashigawa","year":"1998","unstructured":"Kobashigawa J, Miller L, Renlund D, Mentzer R, Alderman E, Bourge R, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation. 1998;66:507\u201315.","journal-title":"Transplantation"},{"key":"1066_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","volume":"4","author":"K Budde","year":"2004","unstructured":"Budde K, Curtis J, Knoll G, Chan L, Neumayer HH, Seifu Y, et al. Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study. Am J Transpl. 2004;4:237\u201343.","journal-title":"Am J Transpl"},{"key":"1066_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.transproceed.2011.12.023","volume":"44","author":"PC Lee","year":"2012","unstructured":"Lee PC, Chang SS, Shieh SC, Wu ZC, Wang WM, Wang JD, et al. Cyclosporine or tacrolimus: which is the better partner for myfortic or cellcept? Transpl Proc. 2012;44:137\u20139.","journal-title":"Transpl Proc"},{"key":"1066_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1399-0012.2006.00569.x","volume":"21","author":"M Hummel","year":"2007","unstructured":"Hummel M, Yonan N, Ross H, Miller LW, Sechaud R, Balez S, et al. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients. Clin Transpl. 2007;21:18\u201323.","journal-title":"Clin Transpl"},{"key":"1066_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509\u201316.","journal-title":"Am J Ophthalmol"},{"key":"1066_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/rheumatology\/33.2.115","volume":"33","author":"TW O\u2019Neill","year":"1994","unstructured":"O\u2019Neill TW, Rigby AS, Silman AJ, Barnes C. Validation of the International Study Group criteria for Behcet\u2019s disease. Br J Rheumatol. 1994;33:115\u20137.","journal-title":"Br J Rheumatol"},{"key":"1066_CR19","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647\u201352.","journal-title":"Am J Ophthalmol"},{"key":"1066_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/bjophthalmol-2015-306701","volume":"100","author":"D Doycheva","year":"2016","unstructured":"Doycheva D, Zierhut M, Blumenstock G, Sobolewska B, Voykov B, Hohmann J, et al. Mycophenolate sodium for the treatment of chronic non-infectious uveitis of childhood. Br J Ophthalmol. 2016;100:1071\u20135.","journal-title":"Br J Ophthalmol"},{"key":"1066_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/bjophthalmol-2017-310156","volume":"102","author":"CME Deuter","year":"2018","unstructured":"Deuter CME, Engelmann K, Heiligenhaus A, Lanzl I, Mackensen F, Ness T, et al. Enteric-coated mycophenolate sodium in the treatment of non-infectious intermediate uveitis: results of a prospective, controlled, randomised, open-label, early terminated multicentre trial. Br J Ophthalmol. 2018;102:647\u201353.","journal-title":"Br J Ophthalmol"},{"key":"1066_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/bjophthalmol-2014-305535","volume":"99","author":"D Doycheva","year":"2015","unstructured":"Doycheva D, Jagle H, Zierhut M, Deuter C, Blumenstock G, Schiefer U, et al. Mycophenolic acid in the treatment of birdshot chorioretinopathy: long-term follow-up. Br J Ophthalmol. 2015;99:87\u201391.","journal-title":"Br J Ophthalmol"},{"key":"1066_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","volume":"125","author":"AD Dick","year":"2018","unstructured":"Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr, Brezin AP, Chee SP, et al. Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative. Ophthalmology. 2018;125:757\u201373.","journal-title":"Ophthalmology"},{"key":"1066_CR24","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s10792-018-0949-4","volume":"39","author":"CP Herbort Jr","year":"2019","unstructured":"Herbort CP Jr, Abu El Asrar AM, Takeuchi M, Pav\u00e9sio CE, Couto C, Hedayatfar A, et al. Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease. Int Ophthalmol. 2019;39:1419\u201325.","journal-title":"Int Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-1066-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-1066-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-020-1066-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:12:30Z","timestamp":1684617150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-1066-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-1066-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"10 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Medical Ethics Committee approval # NCT01261169, Chang Gung Memorial Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}